BridgeMD
New treatment option for COPD Exacerbation
Official title High-intensity Resistance Training in Post-exacerbation COPD
ClinicalTrials.gov ID: NCT07302425
What this study is testing
- What it's testing
- After a COPD exacerbation, many individuals experience severe weakness in the leg muscles, especially the quadriceps. This weakness can make daily activities difficult and slow down recovery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- COPD diagnosis according to the GOLD guidelines [11] with FEV1/FVC \<70%
- Stable clinical condition (pH\>7.30) [11]
- Hospital discharge within 3 weeks from an event of hospitalization due to an acute exacerbation of COPD.
- Absence of significant motor disability, described by the possibility of performing the 6MWT.
You likely can't join if
- Presence of lung diseases other than COPD
- Orthopedic and neurological conditions that prevent the execution of functional tests
- Severe neurological and cardiologic comorbidities or other severe diseases compromise exercise tolerance.
- Cognitive impairment evaluated by Mini-Mental State Examination (MMSE) score as \< 25.
The study team makes the final eligibility decision.
Where it's taking place
- Lumezzane, Brescia, Italy
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lumezzane, Brescia, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.